Flynn James E 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-26 3:53 pm Sale |
2021-03-22 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 161,714 1.940% |
-774,577 (-82.73%) |
Filing |
| 2021-02-12 12:28 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 936,291 11.280% |
936,291 (New Position) |
Filing |